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Abstract
The available data suggests that hypotension caused by Hg2+ adminis-
tration may be produced by a reduction of cardiac contractility or by
cholinergic mechanisms. The hemodynamic effects of an intravenous
injection of HgCl2 (5 mg/kg) were studied in anesthetized rats (N = 12)
by monitoring left and right ventricular (LV and RV) systolic and
diastolic pressures for 120 min. After HgCl2 administration the LV
systolic pressure decreased only after 40 min (99 – 3.3 to 85 – 8.8
mmHg at 80 min). However, RV systolic pressure increased, initially
slowly but faster after 30 min (25 – 1.8 to 42 – 1.6 mmHg at 80 min).
Both right and left diastolic pressures increased after HgCl2 treatment,
suggesting the development of diastolic ventricular dysfunction. Since
HgCl2 could be increasing pulmonary vascular resistance, isolated
lungs (N = 10) were perfused for 80 min with Krebs solution (continu-
ous flow of 10 ml/min) containing or not 5 µM HgCl2. A continuous
increase in pulmonary vascular resistance was observed, suggesting
the direct effect of Hg2+ on the pulmonary vessels (12 – 0.4 to 29 – 3.2
mmHg at 30 min). To examine the interactions of Hg2+ and changes in
cholinergic activity we analyzed the effects of acetylcholine (Ach) on
mean arterial blood pressure (ABP) in anesthetized rats (N = 9) before
and after Hg2+ treatment (5 mg/kg). Using the same amount and route
used to study the hemodynamic effects we also examined the effects of
Hg2+ administration on heart and plasma cholinesterase activity (N =
10). The in vivo hypotensive response to Ach (0.035 to 10.5 µg) was
reduced after Hg2+ treatment. Cholinesterase activity (µM h-1 mg
protein-1) increased in heart and plasma (32 and 65%, respectively)
after Hg2+ treatment. In conclusion, the reduction in ABP produced by
Hg2+ is not dependent on a putative increase in cholinergic activity.
HgCl2 mainly affects cardiac function. The increased pulmonary
vascular resistance and cardiac failure due to diastolic dysfunction of
both ventricles are factors that might contribute to the reduction of
cardiac output and the fall in arterial pressure.
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Introduction
Acute intravenous (iv) administration of
Hg2+ produces important hemodynamic
changes. The main effect is a progressive
decrease of arterial blood pressure (ABP)
associated with a reduction of heart rate
(HR) (1,2). The mechanisms underlying this
hemodynamic alteration are not known.
Based on present knowledge, the effects of
Hg2+ reducing ABP may result from a reduc-
tion in cardiac mechanical activity (3,4), as
supported by several findings. Inorganic
mercury can produce profound cardiotoxi-
city (1,3-7). Acute HgCl2 poisoning in Lan-
gendorff-perfused rat hearts reduces left ven-
tricular isovolumic systolic pressure and HR
and delays atrio-ventricular conduction (2,3).
In isolated papillary muscles 1 µM HgCl2
increases force and rate of force develop-
ment but above this concentration force is
reduced (4,7). These cardiac effects result
from a calcium overload developed as a
consequence of the reduction of the sar-
colemmal Na+,K+-ATPase (8-13) and of the
sarcoplasmic reticulum (SR) Ca2+-ATPase
activities (6,9,14,15). Simultaneous effects
of Hg2+ on the Ca2+ channels of the SR also
occur, increasing Ca2+ release (16,17). Stud-
ies from our laboratory using tetanic con-
tractions of isolated papillary muscles also
suggested that a reduction in force might
also result from the toxic effects of HgCl2 on
the contractile proteins (4). The participa-
tion of cholinergic mechanisms was also
suggested by results showing that atropine
pretreatment blocks the hypotensive effect
(2). However, a vasodilatory effect is un-
likely since previous reports have suggested
that Hg2+ induces vasoconstriction (18).
The present study was performed to ex-
amine the hemodynamic changes produced
by acute administration of HgCl2. The study
was conducted on anesthetized rats by meas-
uring pressure development in both ven-
tricles. We also studied the metals effects
on the isolated perfused vascular bed from
the rat lung. To determine whether Hg2+
affects cholinergic mechanisms we analyzed
the effects of acetylcholine (Ach) on ABP
before and after Hg2+ treatment. In addition,
we measured the effects of Hg2+ on heart and
plasma pseudocholinesterase activity.
Material and Methods
General methods
Studies were performed on 42 Wistar rats
(150-330 g) of both sexes. Care and use of
laboratory animals were in accordance with
established NIH guidelines. All rats had free
access to water and were fed rat chow ad
libitum.
Experimental protocols
Hemodynamic effects of HgCl2. Rats were
anesthetized with urethane (1.2 g/kg, ip) and
the carotid artery and jugular and femoral
veins were cannulated. The carotid artery
and jugular vein cannulas were advanced
into the left and right ventricular chambers,
respectively, and connected to pressure trans-
ducers (Gold P23XL) to measure ventricular
pressure (RG-300, FUNBEC). The electro-
cardiogram was also recorded (ME 100,
FUNBEC) with electrodes placed according
to the human standard using the D1 lead.
The following parameters were analyzed:
left ventricular (LV) and right ventricular
(RV) systolic and end-diastolic pressures
(LVSP, LVDP, RVSP and RVDP, respec-
tively) and HR.
The following protocol was used: acute
effects were achieved using an in bolus dose
of HgCl2 injected intravenously (5 mg/kg).
This dose was selected to provide acute toxic
concentrations above 10 µg/ml in blood,
considering that the amount injected would
be diluted in 40 ml of extracellular fluid per
100 g of body weight. According to Bakir et
al. (19), 5 µg/ml of mercury in the blood
causes 28% of deaths in humans. All ani-
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mals (N = 7) were followed for 120 min and
LV and RV pressures and ECG were re-
corded before (control condition - C) and at
1, 3, 5, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90,
100, 110 and 120 min after HgCl2 adminis-
tration. Similar protocols were repeated in
control animals (N = 5) without HgCl2 injec-
tion.
Lung perfusion. To assess the effects of
Hg2+ on lung vascular resistance we per-
fused rat lungs using a technique similar to
that used for the rat tail vascular bed (20).
Rats were anesthetized with sodium pento-
barbital (65 mg/kg, ip) and received 500
units of heparin, ip. After 10 min the thorax
was opened and a cannula was placed inside
the pulmonary artery to perfuse the lungs.
The heart and lungs were then excised and
placed in a temperature-controlled tissue
bath. The heart was not separated from the
lungs to avoid lesion of structures. Thus, the
nutrient solution was infused through both
lungs by the pulmonary artery, returning to
the left atria and ventricle. The pulmonary
artery was perfused with Krebs-Henseleit
(KH) bicarbonate buffer solution, pH 7.4,
bubbled with 5% CO2-95% O2 (27.2 mM
NaHCO3, 119 mM NaCl, 1 mM NaH2PO4,
1.2 mM MgSO4, 2.5 mM CaCl2.2H2O, 11
mM glucose, 5.4 mM KCl and 0.03 mM
EDTA), at 36 – 0.5oC, using a peristaltic
pump at a constant flow of 10 ml/min. The
pulmonary perfusion pressure was measured
with a TP-200T-Nihon-Kohden pressure
transducer (connected to an MP-100
FUNBEC preamplifier) placed between the
pump and the arterial cannula and recorded
continuously on a polygraphic (ANAMED,
AM-820) recorder.
Since lungs appeared to be in good con-
dition indicated by a clear aspect and float-
ing in the tissue bath, after a 10- to 15-min
equilibration period the experimental proto-
col was initiated. The mean perfusion pres-
sure of the pulmonary artery (PMPP) was
measured under control conditions and fol-
lowed for 50 min during continuous infusion
of normal Krebs (N = 5) or Krebs containing
5 µM HgCl2 (1360 ng/ml) (N = 5); PMPP
was then measured at 5, 10, 15, 20, 30, 40
and 50 min. A similar protocol was repeated
in lungs perfused without HgCl2. Since PMPP
increased during Hg2+ infusion pulmonary
edema occurred which was confirmed by the
observation of a shining lung surface and the
complete sinking of the lungs into the solu-
tion.
Effects of mercury on cholinergic activ-
ity. Effects of mercury on cholinergic activ-
ity were evaluated using 2 protocols. Proto-
col 1: effects of HgCl2 on the hypotensive
response elicited by Ach. Nine rats were
anesthetized with sodium pentobarbital (65
mg/kg, ip) and implanted with arterial and
venous cannulae. Increasing doses of Ach
(0.035, 0.105, 0.35, 1.05, 3.5 or 10.5 µg)
were administered iv before and 30 min after
iv injection of HgCl2 (5 mg/kg). The magni-
tude of the peak decrease in mean blood
pressure (MBP) elicited by all doses of Ach
was recorded. Protocol 2: effects of HgCl2
on heart and plasma cholinesterase activity.
Two groups of rats were anesthetized with
pentobarbital and prepared with cannulae as
described above. Six rats received an injec-
tion of HgCl2 (5 mg/kg, iv), while 5 control
rats received iv injections of saline. Fifteen
minutes after the injections the rats were
killed by decapitation and heart and blood
samples were collected. The cardiac tissue
was immediately homogenized in 0.32 M
saccharose plus 10 mM Tris-HCl solution,
pH 7.5 (1 g of tissue per 10 ml of solution)
and centrifuged at 1,000 rpm for 10 min.
Plasma and tissue pseudocholinesterase ac-
tivity (µM h-1 mg protein-1) was measured
using the method of Ellman et al. (21). Pro-
tein was determined by the Coomassie blue
method (22) with bovine serum albumin as a
standard.
Drugs used
Ach, HgCl2, urethane and pentobarbital
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were purchased from Sigma Chemical Co.,
St. Louis, MO; heparin was purchased from
Roche Pharmaceuticals, Sªo Paulo, SP, Bra-
zil.
Data analysis
Data are reported as mean – SEM. Com-
parisons between means were made using a
repeated-measures ANOVA or the Student
t-test. A significant ANOVA was followed
by a Tukey test to compare the means. The
level of significance was set at P<0.05.
Results
Hemodynamic studies
Figure 1 shows that 1 min after HgCl2 iv
injection there was a small increase in RVSP
and a small decrease in LVSP. RVSP showed
minor changes up to the 20th minute while
LVSP did not change until the 40th minute.
Then RVSP began to increase continuously,
attaining an increment of 60% after 80 min.
LVSP tended to decrease attaining a small
but significant decrement of 20% only after
80 min. RVSP and LVSP of control rats did
not change throughout the experiment (Table
1). The diastolic pressure of both RV and LV
suddenly increased after HgCl2 injection (Fig-
ure 2) and showed a continuous tendency to
increase thereafter.
Perfused lungs
Since there was an increase in RV sys-
tolic and diastolic pressures after Hg2+ treat-
ment the possibility of a pulmonary vaso-
constrictor effect produced by the metal was
considered. Isolated lungs were then per-
fused with a constant flow (10 ml/min) to
investigate this possibility. After the begin-
ning of continuous HgCl2 infusion PMPP
increased continuously (Figure 3) while no
changes were observed in untreated lungs
(Table 1). If we plot PMPP and RVSP it can
Table 1 - Time course changes of left ventricular (LV), right ventricular (RV), systolic
(SP) and diastolic (DP) pressures of untreated rats and pulmonary mean perfusion
pressure (PMPP) of untreated isolated perfused lungs.
Time (min) LV RV Lungs
SP DP SP DP PMPP
(mmHg) (mmHg) (mmHg) (mmHg) (mmHg)
0 93 ± 5 4 ± 1.7 23 ± 1.0 3 ± 0.7 19 ± 0.3
1 93 ± 5 5 ± 1.7 23 ± 0.6 4 ± 0.5 -
3 91 ± 5 4 ± 1.6 22 ± 0.5 3 ± 0.4 -
5 92 ± 5 4 ± 1.7 22 ± 0.4 3 ± 0.4 19 ± 0.8
10 91 ± 5 4 ± 1.7 23 ± 1.1 3 ± 0.4 18 ± 1.8
15 91 ± 4 5 ± 1.4 22 ± 0.7 3 ± 0.25 16 ± 4.1
20 90 ± 5 4 ± 1.7 22 ± 0.6 3 ± 0.4 17 ± 5.2
30 92 ± 5 4 ± 0.7 22 ± 0.6 4 ± 0.9 -
40 92 ± 5 4 ± 0.8 22 ± 0.9 3 ± 0.5 -
50 92 ± 5 4 ± 0.5 22 ± 1.0 3 ± 0.4 16 ± 5.5
60 92 ± 5 4 ± 0.4 23 ± 1.0 3 ± 0.25 -
70 92 ± 4 4 ± 0.8 22 ± 1.0 4 ± 0.25 -
80 93 ± 5 4 ± 0.8 22 ± 1.0 4 ± 0.6 -
Figure 1 - Effects of HgCl2 on the time course changes of systolic pressure (SP) in the right
ventricle (RV) (circles) and left ventricle (LV) (triangles) of anesthetized rats. Zero time is the
control condition of the RV or LV systolic pressure obtained before HgCl2 administration (5
mg/kg). Each symbol indicates the mean ± SEM. *P<0.05, one-way ANOVA used to
compare the time course changes of RV or LV systolic pressure to their respective controls.
Observe that there were only minor changes in LV systolic pressure, whereas changes in
RV systolic pressure were more significant.
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be seen that both variables increase in paral-
lel up to 30 min after the beginning of con-
tinuous HgCl2 infusion (Figure 3). It is inter-
esting to point out that about this time the
PMPP begins to fall and this is coincident
with signs of pulmonary edema (32 – 2.9
mmHg). Indeed, signs of pulmonary edema
(dyspnea, tachypnea, pulmonary rales) also
occurred in anesthetized rats at a not too
different RVSP (41.6 – 1.61 mmHg). This
usually happened 50 min after the beginning
of HgCl2 administration and was followed
by intense dyspnea and death of the rats at 80
min.
Effects of mercury on cholinergic activity
Intravenous administration of Ach elic-
ited dose-related decreases in MBP and HR
(Figure 4). Administration of HgCl2 reduced
the magnitude of the hypotensive response
to all doses of Ach (Figure 4). Regarding
heart rate, only at the dose of 3.5 µg was the
bradycardic response significantly attenu-
ated. All the other bradycardic responses
were similar to the pretreatment response.
To determine whether Hg2+ decreased
the hypotensive response to Ach by increas-
ing cholinesterase activity we measured the
specific activity of cholinesterase in the
plasma and heart of Hg2+-treated and saline-
treated rats. Hg2+ treatment significantly
increased cholinesterase activity in heart
and plasma by 32 and 65%, respectively
(Table 2).
Discussion
The present results support the view that
the reduction of ABP caused by acute ad-
ministration of Hg2+ in vivo depends mainly
on the depression of cardiac mechanical func-
tion. This depression resulted from the de-
velopment of diastolic dysfunction of both
ventricles plus pulmonary hypertension.
Previous reports showed that one of the
main cardiovascular changes occurring in
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Figure 2 - Effects of HgCl2, 5 mg/kg, on the time course changes in diastolic pressures (DP)
of the right ventricle (RV) (circles) and left ventricle (LV) (triangles) of anesthetized rats. Zero
time is the control condition of the RV or LV diastolic pressure obtained before HgCl2
administration. Each symbol represents the mean ± SEM. *P<0.05, one-way ANOVA used
to compare the time course changes of RV or LV diastolic pressures to its respective
control. Observe that DPs, in contrast to the systolic pressure changes, increased progres-
sively for both ventricular chambers.
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response to the acute administration of Hg2+
in vivo was a reduction in ABP (1,2). The
reduction of ABP could result from the dete-
rioration of cardiac mechanical function
(1,2,4,5,7) and perhaps interactions of Hg2+
and cholinergic mechanisms could account
for the ABP reduction since atropine blocks
the Hg2+-induced hypotension (2). The pur-
pose of our study was to determine whether
any or all of these possible mechanisms were
responsible for the reduction of ABP caused
by Hg2+.
Hemodynamic effects of Hg2+
One of the main mechanisms which may
account for the hypotensive response to Hg2+
is a direct effect reducing myocardial perfor-
mance (1,2,4,5,7). Acute HgCl2 poisoning in
Langendorff-perfused rat hearts reduced the
left ventricular systolic pressure and heart
rate and delayed atrioventricular conduction
(2,3). In addition, other studies from our
laboratory using tetanic contractions of iso-
lated papillary muscles also suggested that
the force reduction could result from the
effect of HgCl2 on contractile proteins (4).
Only an important reduction in ABP was
described for acute cardiovascular toxic ef-
fects in vivo (1,2). At least two aspects may
contribute to this fall in ABP. Firstly, since
Hg2+ affects the cardiac contractile activity
in isolated preparations the reduction in ABP
observed in vivo could result from an altered
mechanical cardiac function. The second
could be a depressed vascular smooth muscle
contraction produced by Hg2+ which may
reduce ABP. This is unlikely since previous
findings showed that Hg2+ induces vasocon-
striction (18). These observations raised two
possibilities to explain the reduction in ABP:
cardiac mechanical failure and/or pulmo-
nary hypertension caused by pulmonary va-
soconstriction. These questions were inves-
tigated by studying the acute effects of the
metal in anesthetized rats, measuring LV
and RV systolic and diastolic pressures, and
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Figure 4 - Effects of increasing concentrations of acetylcholine (Ach) on mean blood
pressure (MBP) and heart rate (HR) before (control) and after HgCl2 (Hg2+) treatment (5 mg/
kg). a, b, c, d, e and f correspond to increasing concentrations of Ach (0.035, 0.105, 0.35,
1.05, 3.5 and 10.5 µg, respectively) injected iv. Each column represents the mean and the
bars one SEM. Two-way ANOVA indicated a significant decrease in MBP and HR. *P<0.005
for Ach vs Ach-free, both before and after Hg2+ treatment and +P<0.01 for differences
between each Ach effect before and after Hg2+ treatment.
Table 2 - Cholinesterase activity (µM h-1 mg protein-1) measured in heart and plasma
before (control) and after HgCl2 treatment.
Data are reported as mean ± SEM. N = Number of experiments. *P<0.01 compared to
control (Student t-test).
Control HgCl2 (5 mg/kg)
Heart 0.76 ± 0.04 (N = 5) 1.0 ± 0.09 (N = 6)* 32% activation
Plasma 0.23 ± 0.04 (N = 5) 0.38 ± 0.07 (N = 6)* 65% activation
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on the isolated perfused lung.
For the anesthetized rat the results did not
show appreciable changes of LVSP during
the first 40 min after HgCl2 administration.
Only after this period of time was a small
reduction of LVSP observed. The results
suggest that this dose of HgCl2, in vivo, does
not produce an important depression of LVSP
and cannot explain the reduction of ABP, as
we observed before (2). In contrast, RVSP
increased slowly during the first 30 min and
then more steeply. Results also indicated
that RV pressure development was preserved
and the progressive increment of RVSP could
be the result of increased pulmonary vascu-
lar resistance. Hg2+ has been reported to
constrict the rat tail artery (18) and other
types of smooth muscle such as guinea pig
ileum and vas deferens (23). In guinea pig
ileum and vas deferens, Hg2+ increases basal
tone at low concentrations (10-9-10-8 M) by
stimulating autonomic neuromuscular trans-
mission. At higher concentrations (10-4 M),
Hg2+ produces smooth muscle contraction
by a direct action.
To answer this question, we perfused
isolated lungs at constant flow to measure
pulmonary resistance. Again, the increase in
vascular resistance produced by HgCl2 was
demonstrable and this increased pulmonary
resistance could explain the fall in ABP by
reducing cardiac output. Although this was
not the main goal of the present work, this
finding deserves additional comments.
Magos et al. (24) reported that the lung is an
important site in the removal of elemental
Hg2+ from the blood stream. According to
these authors, after an intravenous dose of
elemental Hg2+ dissolved in aqueous buffer
10 to 20% of the metal may be exhaled.
Thereafter, if Hg2+ increases pulmonary vas-
cular resistance, special attention should be
given to diagnostic procedures requiring Hg2+
salts, like lung scintigraphy.
Another interesting aspect resulting from
HgCl2 administration was the important in-
crease of the RV and LV diastolic pressures.
Two main mechanisms could explain these
findings. First, this could result from an in-
crease in the afterload of both ventricles.
However, although being true for the RV,
since pulmonary resistance increased, this is
unlikely for the LV because the afterload for
this chamber decreased as its diastolic pres-
sure increased. The second mechanism could
explain the increment of diastolic pressure
for both ventricular chambers. This could be
the result of a calcium overload since Hg2+
reduces the activity of the calcium (14,15)
and sodium pumps (8-13) and increases cal-
cium release from SR (4,16,17). The occur-
rence of a calcium overload may impair
relaxation and cardiac filling during dias-
tole, thereafter reducing cardiac output and
then ABP.
Effects of Hg2+ on cholinergic activity
Previous studies using atropine showed
that the decrease in MBP elicited by HgCl2
could be attenuated by prior administration
of atropine (2). Several reports presented
results which suggested interactions between
Hg2+ and cholinergic activities. Burg and
coworkers (25) suggested that Hg2+ binds to
muscarinic receptors in rat brain prepara-
tions. Interactions of HgCl2 and CH3HgOH
with muscarinic receptor subtypes in the rat
brain were also described by Castoldi et al.
(26). Kostial and Landeka (27) suggested
that Hg2+ might stimulate the release of Ach
from nerve terminals. Candura et al. (28)
presented similar findings which suggested
that small concentrations of Hg2+ stimulate
cholinergic transmission while high concen-
trations inhibit it. Inhibition of cholinergic
transmission was also reported by Moberg et
al. (23). Mercury may also interfere with
cholinergic transmission by blocking Ca2+-
dependent Ach release and enhancing Ca2+-
independent release in nerve terminals (29).
These facts could explain why atropine an-
tagonized the effects of Hg2+.
The administration of HgCl2 attenuated,
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instead of enhancing, the hypotensive and
bradycardic responses elicited by exogenous
Ach. The explanation for these findings was
the observation that Hg2+ increased cholin-
esterase activity in both plasma and heart.
The increased activity of the enzyme may
have degraded the exogenously administered
Ach before it reached the receptor. How-
ever, many reports regarding cholinesterase
activity suggested that Hg2+ strongly inhibits
this enzyme (30-33) instead of activating it.
Our results do not permit a clear explanation
for this controversy but some results in the
literature may help to explain it. Previous
reports showed that the effects of Hg2+ on
enzyme activities may differ according to
the enzyme affected (34,35) and even within
the different organs in the same animal (36).
Other reports even suggested that acetylcho-
linesterase or cholinesterase are not affected
by Hg2+ (37,38). Another aspect to be con-
sidered is the difference between our proto-
col and others reported in the literature. Ours
was an acute in vivo protocol while all others
were performed over a longer period of time,
usually days, or in vitro. We may speculate
that the activity of plasma and heart cho-
linesterase may increase just after Hg2+ in-
jection and progressively decrease with the
continuation of the toxic effects of the metal.
Another explanation for the attenuation
of the hypotensive and bradycardic responses
to exogenous Ach by Hg2+ may be the im-
pairment of cholinergic transmission. The
same explanation is valid for the effects of
atropine since atropine may interfere with
the interactions between Hg2+ and the mus-
carinic receptors. However, taken together,
these findings indicate that the interactions
with cholinergic mechanisms may not be a
pivotal mechanism to explain the reduction
in ABP produced by Hg2+.
In summary, our results confirm previ-
ous findings showing that acute administra-
tion of Hg2+ decreases ABP in rats. The
present results suggest for the first time that
HgCl2 may produce cardiac diastolic failure
and pulmonary hypertension in vivo, which
may be the main mechanism producing the
significant ABP reduction caused by HgCl2.
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